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As 2010 draws to a close, Current Biology completes its 
twentieth year of publication — were the journal a person, 
it would turn 20 with the new year, but as journals are 
deemed to be age (volume) one in their first year, the 
volume number is one ahead of the chronological age. All 
of which is by way of a long-winded justification for writing 
about this anniversary now, rather than at the beginning of 
the year.
I think journal editors can overestimate the level of 
outside interest and excitement about their journal’s 
anniversary, but nevertheless I will take this opportunity 
to say something about the journal and its history, which 
is somewhat unusual. As Peter Newmark, our founder, 
recounts below, Current Biology started life, in 1991, as 
a bi-monthly tertiary journal, publishing commentaries 
(dispatches) on recent advances in — to use the journal’s 
then-stated description — “modern” biology, by which 
it meant biology in the “new” molecular tradition. If you 
look over early issues of the journal you will note a rather 
distinctive visual style, with curious occasional woodcuts 
and cartoons, and plenty of (then unusual) computer-
drawn colour illustrations (some impression of our early 
style is given by the cover of our first issue, shown in  
the figure).
The journal was owned originally by the Current Science 
group, which also published the biological Current Opinion 
journals. This was a relatively small, privately owned 
publishing company, which put a lot of emphasis on 
innovation and the use of computer technology — hence 
the extensive computer graphics and computer-based 
typesetting — all old-hat now, but back then just coming 
into publishing (in my 11 years at Nature, I never had use  
of a computer).
I joined the journal, from Nature (like Peter Newmark), in 
1992, and we took the opportunity to turn Current Biology 
into a primary journal — I cannot think of another review 
journal that has transformed to one (also) publishing 
research papers. In retrospect, we were overly optimistic 
about the speed with which we would take off and 
become, as we hoped, one of the ‘top’ primary journals 
in biology. The initial rate of submissions was rather low, 
and for several years we published just a few papers per 
issue — we had the luxury of being able to do this because 
of our extensive, popular dispatch section, which had 
already attracted a significant following.
We were somewhat naive in believing that, by being new, 
looking good and having extensive experience and a large 
network of contacts from working at Nature, we would 
have no trouble attracting authors with exciting results to 
report. It is clear now that this was not sufficient. It is very 
hard to get a general journal off the ground when you are 
by definition not aiming at a specific subject niche and 
without some strong backing force, as benefited the Public 
Library of Science, which started a journal with similar 
scope on the back of the open access movement.
Our emphasis was not on niche or business model, but 
rather on quality of editorial service, and quality of product. Peer review remains a constant topic of discussion: we 
have always been of the view that the issue is not whether 
to have peer review or some alternative, but how to ensure 
that the quality of peer review — and editorial decision 
making — is as good as possible. 
In particular, we wanted to be fast in our assessments 
of papers, and so far as possible to avoid making arbitrary 
editorial decisions after prolonged technical review of a 
paper — this is the reasoning behind our strong emphasis 
on ‘presubmission enquiries’. Popular general journals 
attract far more technically adequate papers than they 
can publish; decisions have to be made about the level of 
interest, the degree of advance, etc. To a large extent, such 
decisions can be made prior to time-consuming formal 
review of the full paper on the basis of a presubmission 
enquiry with an abstract that makes clear what the new 
work adds to the field. 
The second pillar on which we hoped to build was 
the extensive ‘front matter’ section, which started, as 
mentioned, with the dispatches, but has subsequently 
The cover of the first issue of Current Biology.
The general subject headings – Cell Biology, Neurobiology, Immunol-
ogy, Structural Biology and Genetics & Development – and the associ-
ated colours were taken from the equivalent Current Opinion journals.
Current Biology Vol 20 No 24
R1050grown to include all of the formats that are now gathered 
under our “magazine” section, including Primers, Quick 
guides, Q&As, Essays and news articles, in addition to 
the dispatches and full reviews/minireviews. Our aim has 
been for our readers to be able to learn about the major 
developments in any area of biology, and to be able to 
learn about new fields.
We also try to divert and surprise; for example, many of 
our Quick Guides point out features of a particular species 
that may be underappreciated — such as the one we 
published on locusts [1], with their remarkable solitary-
gregarious polyphenism (as the switch to the gregarious 
form is inherited, I am surprised it is not the focus of 
more interest and excitement among those working on 
‘epigenetic’ mechanisms — on which more below). Or 
with a correspondence item that analysed early video 
footage and made inferences about the prevalence of left-
handedness in the Victorian era. As mentioned in a piece 
I wrote last year [2], this feeling that journals benefit from 
‘leavening’ was inherited from my Nature editor, the late 
John Maddox. 
Another aspect of the philosophy that continues to guide 
Current Biology is our interest in all the levels of analysis in 
biology — from biochemical and molecular to ecosystem. 
We are strong in our view that the purpose of biological 
research is not solely to elucidate “mechanisms”. This may 
be most evident in our interest (and strength) in the fields 
of cognitive science and animal behaviour, with the view 
that such research has great intrinsic merit in establishing 
what it is that the brains of human and other organisms 
actually do — and why. For those who might be interested, 
I say more about this in the foreword to the Cold Spring 
Harbor monograph on invertebrate neuroscience that I  
co-edited a few years ago [3].
These approaches and efforts would seem to have 
worked — the journal was acquired by Elsevier in 1998, 
and moved to Cell Press in 2001, and we are now offered 
thousands of papers a year, and have an impact factor in 
double figures. Beyond these simple figures we have a 
strong following of readers in many fields who appreciate 
our approach and who like the journal.
But what of the state of biology in 2010? I am not going 
to say we “live in exciting times” — it is too trite, too often 
said to be very meaningful. There is a vast amount of 
interesting biological research being done, and the amount 
of new “data” that will be acquired in 2011 will be much 
higher than 50 years ago (1961) — but will the essential 
advance in biological understanding really be greater 
than in a year that saw publication of Jacob and Monod’s 
operon model, the great paper on the triplet genetic 
code by Crick, Brenner and colleagues, and the evidence 
proving the existence of messenger RNA?
Unlikely, I think. Biology is at a very different stage 
now than 50 years ago. The fundamental principles 
of molecular biology have been worked out — we 
now understand how biological information is stored, 
expressed and transmitted — and much of the present 
work, in molecular and cellular fields at least, is concerned 
with details of how the expressed information gives rise to 
specific aspects of the phenotype. As my colleague Florian 
Maderspacher [4] argued recently in Current Biology, 
despite attempts of some in the media, there is not going 
to be a new revolution that leads to “victory over the 
gene”, and it seems highly unlikely to me that it will turn How it all began
I can’t recall if it was the morning or the afternoon 
of my first day in my new job that my boss said he 
thought it would be a good idea to start a journal 
to rival Nature, albeit only on the biology side. After 
pausing to gulp, I said “Yes, but….”.
My boss was entrepreneurial publisher Vitek Tracz. 
My job was that of Managing Director of Current 
Biology Ltd., a newly formed company that had two 
Current Opinion titles as its starting point. I had taken 
the job after 16 years at Nature so, naturally, Vitek felt 
I should be able easily to start a rival. 
After a little, or perhaps a lot, of discussion about 
the problems of starting from scratch a high-profile 
journal containing all the elements of Nature, we 
settled on a rather less ambitious starting point. 
This was to publish mini-reviews with the aim of 
bettering the most-read section of Nature — its News 
and Views. We decided to start by publishing them 
every other month during 1991 and giving the journal 
away free to every subscriber to a Current Opinion 
journal as well as to several thousand high-ranking 
biologists. This would build up visibility and, we 
hoped, popularity so that we could then start to sell 
subscriptions, increase the frequency and, at some 
stage, perhaps, start publishing research papers.
We kicked around many ideas for a title but in the 
end couldn’t come up with anything that seemed 
more to the point than “Current Biology”. For the 
mini-reviews we came up with “Dispatches”. And 
for the journal as a whole we coined the slogan 
“Dispatches from the frontlines of Biology”. Twenty-
four dispatches were to be commissioned for each 
issue, with four coming from each of the six areas of 
biology that had been defined by the Current Opinion 
series. They were to be heavily edited and illustrated 
in innovative ways and in colour. I commissioned 
the content. To help me edit it, I hired Kate Hooper, 
an editor from Nature. Celia Welcomme, who had 
brilliantly illustrated the then best-selling immunology 
text book (‘Roitt’) created the style of illustration. 
Vitek, himself, provided the creative input for the 
design of each cover. 
Current Biology kicked off in February 1991 and by 
the end of the year it was clear that we had a success 
on our hands and several thousand subscribers. This 
led us to turn it into a monthly subscription journal, at 
which point I decided I needed a Deputy Editor, a role 
filled by the current Editor, Geoffrey North, in May 
1992. By then, the shall we? / shan’t we? discussions 
had been resolved — we would start publishing 
research papers from the start of 1993.
Peter Newmark
Founding Editor
out that a significant amount of heritable information is 
stored “beyond the genome” [5].
The premature declarations of “victory over the gene” 
illustrate a curious phenomenon that seems to bedevil 
biology: and that is the problem that certain words seem 
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they lose clear meaning. This is seen repeatedly — most 
notably in recent years for the terms “systems biology” 
and “epigenetics”. In the first case, one sees perfectly 
respectable departments of cell biology (for example), 
homes to excellent labs doing great work combining 
experimental approaches with appropriate quantitative 
theory, all of a sudden renaming themselves as 
departments of systems biology, for no substantive reason, 
thereby bracketing their research with bioinformatic studies 
of the kind largely concerned with analysing data (often 
of unclear significance) derived from “high throughput”, 
genomics-related studies. That said, the move to make 
cell and developmental biology more quantitative, to try 
to understand how the components interact to give global 
properties that are not always intuitively obvious, is clearly 
a good thing [6]. The important thing, it seems to me, is 
to have a clear, specific question in mind and not just 
generate a large amount of data and throw up your hands 
saying “what does it all mean?”
The term “epigenetics” seems to be a source of endless 
confusion, a term applied variously to all modifications of 
DNA or associated proteins, to transcriptional “memory” 
(as classically exemplified by the lysogenic state of 
the phage lambda), to characteristics inherited across 
generations that are shown to be independent of the 
genomic DNA sequence. Conferences that, in past years, 
were content to declare their subject as “transcriptional 
regulation” now invariably have to incorporate 
“epigenetics” somewhere into their title. One can only 
hope that, as the fashionable gloss fades with time, clarity 
will reassert itself — at Current Biology we shall continue 
to try to help clarify such matters, as for example with the 
essay we published a few years ago on the use of the word 
“epigenetics” [7]. 
At risk of seemingly overly didactic, there is a point 
worth emphasising that is relevant to discussions 
of epigenetics and (heritable) “information beyond 
the genome”. This is illustrated by the locust 
example mentioned briefly above; such cases of 
inherited polyphenism are not examples of Lamarckian 
evolution — the locust genome itself encodes the potential 
to make two stable phenotypes, either the gregarious 
form or the solitary one. Plasticity is very common in 
biology, from lambda’s ability to be either lysogenic or 
lytic, to plants that grow in different ways in response to 
variations in the environment and nervous systems that 
can learn. Such plasticity can be predictive; this is clearly 
shown by circadian systems, which make changes to 
optimise phenotypes for future conditions. And, in the 
case of inherited polyphenisms, these “predictions” are 
passed across generations. The prediction has to have a physical implementation, which is reasonably described 
as “epigenetic”, and could involve some chemical 
modification of DNA, RNA or associated proteins, or 
involve tightly bound proteins — whatever the actual 
mechanism, it is, in a sense, storing information, but it is 
not independent of (“beyond”) the genome. 
Despite my doubts about whether 2011 will match 1961 
for fundamental advances in understanding, I do think 
that there is much of great interest in current biology. The 
relationship between genetic information and phenotype 
is complex business, and a proper understanding of 
why cells behave as they do, and how the collections of 
cells generated by a fertilised oocyte have the form and 
properties that they have, will require not only chemistry 
and genetics but physics, the application of which to cell 
and developmental biology is gradually increasing.
The brain remains a great frontier of biology, given 
that there is so much that is still very poorly understood. 
Significant advances are of course being made, such as in 
functional imaging and “optogenetics” [8], where genetic 
transformation allows optical control of activity in specific 
neurons. There is still I think, in studies of “higher” brains, 
most particularly the human brain, a sense of the blind 
men studying the elephant by touch. This is of course one 
justification for studying smaller brains, particularly those 
of invertebrates, which despite their size can control a 
highly sophisticated behavioural repertoire [9] — the notion 
that just because an animal lacks a backbone it must be 
“simple” is a myth, as unjustified as the pejorative use of 
the epithet “bird-brained”. 
But, mystery is good; it is good to know things, but it 
is thrilling to know that we have much to learn — while 
it seems unlikely we shall see a year quite like molecular 
biology’s annus mirabilis, 1961, again, there will surely be 
many exciting new developments to report and explain in 
Current Biology in the years to come.
Geoffrey North
Editor
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